3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
4
Phase 2
2
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Lymphoma, T-Cell, Cutaneous
12
Lymphoma
9
Lymphoma, T-Cell
8
Mycosis Fungoides
5
Lymphoma, T-Cell, Peripheral
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia
3
Hematologic Neoplasms
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Immunoblastic Lymphadenopathy
2
Enteropathy-Associated T-Cell Lymphoma
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Interventions
Dexamethasone
129
Lenalidomide
70
Cyclophosphamide
70
Bortezomib
69
Calcium Dobesilate
50
fludarabine
44
pomalidomide
40
daratumumab
37
carfilzomib
33
fludarabine phosphate
31
Melphalan
25
dexamethasone acetate
20
dexamethasone 21-phosphate
20
auricularum
18
Filgrastim
18
Whole-Body Irradiation
14
Biopsy
13
isatuximab
12
Vorinostat
12
Tacrolimus
12
Peripheral Blood Stem Cell Transplantation
12
Magnetic Resonance Spectroscopy
12
Granulocyte Colony-Stimulating Factor
12
Specimen Handling
11
Sirolimus
11
ixazomib
10
belantamab mafodotin
10
Panobinostat
10
Mycophenolic Acid
10
Cyclosporine
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Multiple Myeloma
×
romidepsin
×
Clear all
NCT01742793
2020-03-04
RID
Yale University
Phase 1
Terminated
12 enrolled